Arsenal Capital-backed Lumanity completed the acquisition of Innovative Edge.

Arsenal Capital-backed Lumanity, a medical research comapny, completed the acquisition of Innovative Edge, a provider of pharmaceutical product launch services. Financial terms were not disclosed. "We are delighted to welcome IE to the Lumanity family, further enhancing our asset optimization and commercialization capabilities. We look forward to working with our new colleagues to support the launch of new and transformative products that will improve patient health by accelerating and optimizing access to medical advances," Jon Williams, Lumanity CEO.